← All companies
RCEL
AVITA Medical, Inc.
$4.62
+0.22 +5.00%
Key statistics
from XBRL data in SEC filingsMarket cap
$142M
Revenue (TTM)
$72.3M
Net income (TTM)
-$45.3M
EPS (TTM)
$-1.56
P/E ratio
—
Dividend yield
—
Free cash flow
-$32.2M
Cash
$8.31M
Total assets
$51.5M
Gross margin
81.4%
52-week range
$3.22 – $7.12
Recent SEC filings
40 most recentAnnual, quarterly & current reports
8-K
Entered a material agreement
Jun 8, 2026
8-K
Director or officer change; Shareholder vote results
Jun 4, 2026
10-Q
Quarter ended 2026-03-31
May 14, 2026
8-K
Results of operations (earnings release)
May 14, 2026
8-K
Director or officer change; Regulation FD disclosure
May 1, 2026
10-K
Fiscal year ended 2025-12-31
Feb 12, 2026
8-K
Results of operations (earnings release)
Feb 12, 2026
8-K
Entered a material agreement; Terminated a material agreement; Results of operations (earnings release); Took on a direct financial obligation; Unregistered sale of equity
Jan 13, 2026
8-K
Director or officer change
Jan 5, 2026
10-Q
Quarter ended 2025-09-30
Nov 6, 2025
8-K
Entered a material agreement; Results of operations (earnings release)
Nov 6, 2025
8-K
Director or officer change; Regulation FD disclosure
Oct 17, 2025
8-K
Unregistered sale of equity
Aug 18, 2025
8-K
Other events
Aug 12, 2025
10-Q
Quarter ended 2025-06-30
Aug 8, 2025
8-K
Entered a material agreement; Results of operations (earnings release)
Aug 7, 2025
8-K
Director or officer change
Aug 6, 2025
8-K
Director or officer change; Shareholder vote results
Jun 5, 2025
8-K
Amended charter or bylaws
May 15, 2025
10-Q
Quarter ended 2025-03-31
May 8, 2025
8-K
Results of operations (earnings release)
May 8, 2025
8-K
Entered a material agreement; Regulation FD disclosure
Mar 17, 2025
10-K
Fiscal year ended 2024-12-31
Feb 13, 2025
8-K
Entered a material agreement; Results of operations (earnings release)
Feb 13, 2025
8-K
Results of operations (earnings release)
Jan 7, 2025
10-Q
Quarter ended 2024-09-30
Nov 7, 2024
8-K
Results of operations (earnings release); Other events
Nov 7, 2024
10-Q
Quarter ended 2024-06-30
Aug 8, 2024
8-K
Results of operations (earnings release)
Aug 8, 2024
8-K
Entered a material agreement; Regulation FD disclosure
Jul 31, 2024
8-K
Director or officer change; Regulation FD disclosure
Jul 1, 2024
8-K
Director or officer change; Shareholder vote results
Jun 6, 2024
8-K
Other events
May 30, 2024
10-Q
Quarter ended 2024-03-31
May 13, 2024
8-K
Results of operations (earnings release)
May 13, 2024
8-K
Results of operations (earnings release)
Apr 11, 2024
10-K
Fiscal year ended 2023-12-31
Feb 22, 2024
8-K
Results of operations (earnings release)
Feb 22, 2024
8-K
Entered a material agreement; Results of operations (earnings release); Regulation FD disclosure
Jan 10, 2024
8-K
Results of operations (earnings release)
Nov 9, 2023